
(HealthDay News) – The U.S. Food and Drug Administration on Wednesday approved the first pill form of fecal microbiota — similar to what’s known as fecal transplant therapy — to treat the bacterial infection Clostridioides difficile, one of the most common and deadly infections found in health care settings. The drug, Vowst, is approved to… read on > read on >